e-Therapeutics Plc - Company Profile
Powered by
All the data and insights you need on e-Therapeutics Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date e-Therapeutics Plc Strategy Report
- Understand e-Therapeutics Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on e-Therapeutics Plc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4357334A2 | Application | Konjugierte oligonukleotidverbindungen, verfahren zur herstellung und verwendungen davon | A61K47/549; C07D207/404; C07H15/04; C07H15/08; C07H21/00; C07H21/02; C07H21/04; C12N15/113; C12N2310/14; C12N2310/313; C12N2310/315; C12N2310/317; C12N2310/351; C12N2320/32; C12N2330/30 | April 24, 2024 |
US20240102008A1 | Application | Conjugated oligonucleotide compounds, methods of making and uses thereof | C12N15/113; C12N2310/14; C12N2310/313; C12N2310/315; C12N2310/317; C12N2310/351; C12N2320/32; C12N2330/30 | March 28, 2024 |
EP4175965B1 | Grant | Konjugierte oligonukleotidverbindungen, verfahren zur herstellung und verwendungen davon | A61K47/549; C07D207/404; C07H15/04; C07H15/08; C07H21/00; C07H21/02; C07H21/04; C12N15/113; C12N2310/14; C12N2310/313; C12N2310/315; C12N2310/317; C12N2310/351; C12N2320/32; C12N2330/30 | March 13, 2024 |
WO2024023252A3 | Application | Nucleic acid compounds | C12N15/113; C12N2310/14; C12N2310/315; C12N2310/321; C12N2310/322 | March 07, 2024 |
WO2024023267A3 | Application | Nucleic acid compounds | C12N15/1137; C12N2310/14; C12N2310/315; C12N2310/321; C12N2310/322; C12Y204/01038 | March 07, 2024 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer